ResearcherWenzhou Medical UniversityNo recent work listed

Chao Hui ZHOU

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8839-980X; OpenAlex author ID A5021936583. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper

Papers 1

Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth. Co-author DOI 10.1038/s41419-017-0196-z ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hongwei Sun · 1 shared paper, 2018 · strength 0.07
- Paper Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer… DOI 10.1038/s41419-017-0196-z ↗
Jianxin Lyu · 1 shared paper, 2018 · strength 0.07
- Paper Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer… DOI 10.1038/s41419-017-0196-z ↗
Jing Gao · 1 shared paper, 2018 · strength 0.07
- Paper Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer… DOI 10.1038/s41419-017-0196-z ↗
Hezhi Fang · 1 shared paper, 2018 · strength 0.07
- Paper Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer… DOI 10.1038/s41419-017-0196-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.